Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus with UVB Phototherapy for Vitiligo
NCT05577637Phase 1Completed
- Sponsor
- Combined Military Hospital Abbottabad
- Start
- May 2021
- Primary completion
- Nov 2021
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Vitiligo comparing Tacrolimus + UVB with Placebo + UVB (2 arms). Primary endpoint: Percentage of Repigmentation at 12 weeks. Started May 2021; status: completed.
02
Drugs
tacrolimus
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT05577637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05577637.